Innoviva (INVA) Total Debt Growth (1y) (2011 - 2026)
Innoviva (INVA) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - | - |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - | - |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.61 Bn | 1.01 Bn | 75.83 Mn | -42.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.50% |
| Dec 31, 2025 | -42.51% |
| Sep 30, 2025 | -42.53% |
| Jun 30, 2025 | 0.37% |
| Mar 31, 2025 | 0.48% |
| Dec 31, 2024 | 0.47% |
| Sep 30, 2024 | 0.47% |
| Jun 30, 2024 | 0.47% |
| Mar 31, 2024 | 0.46% |
| Dec 31, 2023 | -17.42% |
| Sep 30, 2023 | -17.43% |
| Jun 30, 2023 | 363.40% |
| Mar 31, 2023 | 363.14% |
| Dec 31, 2022 | 36.92% |
| Sep 30, 2022 | 37.60% |
| Jun 30, 2022 | -75.37% |
| Mar 31, 2022 | -75.24% |
| Dec 31, 2021 | 2.37% |
| Sep 30, 2021 | 2.33% |
| Jun 30, 2021 | 2.30% |